GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
China Hong Kong
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
Trials & Approvals FDA
FDA Gives Emergency Approval to Merck’s COVID-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
Trials & Approvals HIV
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
Trials & Approvals Myasthenia Gravis
argenx’s Novel Treatment for Myasthenia Gravis gets FDA Nod
2021-12-21
China Multiple MyelomaChina NMPA
Antengene’s XPO1 Inhibitor Receives First-In-Class Approval in China for Multiple Myeloma
2021-12-20
Trials & Approvals Alzheimer's Disease
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
Trials & Approvals Graft Versus Host Disease
BMS’ Drug Wins First-In-Class Approval for Prevention of Acute Graft-Versus-Host Disease
2021-12-17
Trials & Approvals Cancer
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
Trials & Approvals Prostate Cancer
Starpharma Announces Encouraging Interim Results for Prostate Cancer Drug
2021-11-27
Trials & Approvals Acute Myeloid Leukemia
FDA Places Clinical Hold on Kura Oncology’s Acute Myeloid Leukemia Therapeutic
2021-11-25
Trials & Approvals Organ Transplant
Takeda’s Livtencity Bags FDA Approval for the Treatment of Post-Transplant Infection
2021-11-24
Trials & Approvals Cancer
FDA Approves Aadi Bioscience’s First Product to Treat Rare Cancer
2021-11-23
Trials & Approvals Gene Therapy
FDA Grants Priority Review for bluebird bio’s β-Thalassemia Gene Therapy
2021-11-23
Trials & Approvals Dwarfism
BioMarin’s Dwarfism Drug Garners FDA Nod Amidst Concerns Over Threat to Dwarf Pride
2021-11-21
Trials & Approvals Keytruda
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
1 … 22 23 24 25 26 … 50
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top